Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$12.4 - $17.6 $202,120 - $286,880
-16,300 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.59 - $14.93 $188,917 - $243,359
16,300 New
16,300 $0
Q1 2020

May 15, 2020

SELL
$9.31 - $21.24 $825,108 - $1.88 Million
-88,626 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$13.91 - $21.48 $362,021 - $559,038
26,026 Added 41.58%
88,626 $1.77 Million
Q3 2019

Nov 14, 2019

SELL
$15.84 - $30.01 $357,984 - $678,226
-22,600 Reduced 26.53%
62,600 $998,000
Q2 2019

Aug 14, 2019

SELL
$17.38 - $26.88 $1.77 Million - $2.74 Million
-101,800 Reduced 54.44%
85,200 $2.29 Million
Q1 2019

May 15, 2019

BUY
$9.2 - $21.21 $1.72 Million - $3.97 Million
187,000 New
187,000 $3.22 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $244M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.